Hematology

MD IQ

News

HAVEN 4: Monthly emicizumab shows value

Emicizumab was effective as a monthly treatment for patients with hemophilia A, both with and without inhibitors, according to an ongoing phase 3...

Conference Coverage

Repeat VTE risk heightened in HIV patients

SEATTLE – Two studies detail the risk factors of first-time venous thromboembolism and heightened incidence of repeat VTE in patients with HIV.

Pages